Explore
Validate
Learn
Western blot
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- V2069 - Provider product page
- Provider
- NSJ Bioreagents
- Product name
- CD47 Antibody
- Antibody type
- Monoclonal
- Antigen
- Intact CD47 purified from placenta was used as the immunogen for this antibody.
- Description
- Protein G purified antibody
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Antibody clone number
- B6H12.2
- Vial size
- 20 µg, 100 µg (with sodium azide), 100 µg (without sodium azide), 7 ml (prediluted for IHC use, if applicable)
- Storage
- Store the CD47 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
Submitted references Efficacy of anti-CD47 antibody-mediated phagocytosis with macrophages against primary effusion lymphoma.
CD47-dependent immunomodulatory and angiogenic activities of extracellular vesicles produced by T cells.
A CD47-blocking TRAIL fusion protein with dual pro-phagocytic and pro-apoptotic anticancer activity.
CD47 in the tumor microenvironment limits cooperation between antitumor T-cell immunity and radiotherapy.
Goto H, Kojima Y, Matsuda K, Kariya R, Taura M, Kuwahara K, Nagai H, Katano H, Okada S
European journal of cancer (Oxford, England : 1990) 2014 Jul;50(10):1836-46
European journal of cancer (Oxford, England : 1990) 2014 Jul;50(10):1836-46
CD47-dependent immunomodulatory and angiogenic activities of extracellular vesicles produced by T cells.
Kaur S, Singh SP, Elkahloun AG, Wu W, Abu-Asab MS, Roberts DD
Matrix biology : journal of the International Society for Matrix Biology 2014 Jul;37:49-59
Matrix biology : journal of the International Society for Matrix Biology 2014 Jul;37:49-59
A CD47-blocking TRAIL fusion protein with dual pro-phagocytic and pro-apoptotic anticancer activity.
Wiersma VR, He Y, Samplonius DF, van Ginkel RJ, Gerssen J, Eggleton P, Zhou J, Bremer E, Helfrich W
British journal of haematology 2014 Jan;164(2):304-7
British journal of haematology 2014 Jan;164(2):304-7
CD47 in the tumor microenvironment limits cooperation between antitumor T-cell immunity and radiotherapy.
Soto-Pantoja DR, Terabe M, Ghosh A, Ridnour LA, DeGraff WG, Wink DA, Berzofsky JA, Roberts DD
Cancer research 2014 Dec 1;74(23):6771-83
Cancer research 2014 Dec 1;74(23):6771-83
No comments: Submit comment
Supportive validation
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- Western blot testing of human brain lysate with CD47 antibody (clone B6H12.2). Predicted molecular weight ~35kDa but observed at 35-60kDa depending on glycosylation level.
